Consolidation among big CRO players is continuing to churn. Following a Wednesday afternoon report from the Wall Street Journal saying a deal was close, Thermo Fisher has announced plans to acquire PPD for $17.4 billion. WSJ had reported that the…
FibroGen Plunges on Murky Data Clarification for CKD Drug Roxadustat
Shares of FibroGen were crashing this morning after the company unsuccessfully attempted to express confidence in the benefit/risk profile of its anemia drug, Roxadustat. This comes ahead of the U.S. Food and Drug Administration’s review of the company’s New Drug Application…
AzurRx BioPharma begins trial of niclosamide tablets for Covid-19
AzurRx BioPharma has started its Phase II clinical trial to evaluate micronised oral niclosamide tablets, known as FW-1022, in patients with Covid-19 gastrointestinal (GI) infection. Patient enrolment for the Phase II two-part, two-arm, placebo-controlled RESERVOIR clinical trial is expected to…
Sound Pharmaceuticals to launch NIH-funded Covid-19 oral therapeutic trial
Sound Pharmaceuticals is all set to launch two Phase II clinical trials of an oral capsule, SPI-1005, for treating patients with moderate or severe Covid-19. Developed for various neurotologic, neuropsychiatric, and respiratory indications, SPI-1005 is a capsule with a small…
UNION therapeutics’ Covid-19 candidates meet endpoints in trial
UNION therapeutics has reported that its Covid-19 candidates, inhaled and intranasal niclosamide (UNI91103 and UNI91104), showed a strong safety profile in a Phase I study, meeting the primary endpoints. UNI91103 and UNI91104 are based on a proprietary salt form and…
Syneos Health and Science 37 partner for decentralised trial delivery
Syneos Health has reached a strategic collaboration with Science 37 to enable the delivery of decentralised clinical trials. The integration of Science 37’s technology-first decentralised clinical trial operating system into Syneos Health’s decentralised solutions helps to deliver such clinical trials.…
Pharmaxis to start world-first trial of scar-reducing wound treatment
Australian pharmaceutical research company Pharmaxis has teamed up with the University of Western Australia (UWA) to start a world-first clinical trial to investigate a cream to stop scars forming after trauma, particularly following burn injuries. Australian pharmaceutical research company Pharmaxis…
Launching of Online National Drug Licensing System
In pursuance to implementation of the e-governance, CDSCO has launched various online services. Launching of Online National Drug licensing System (NDLS) portal for issuance of licenses and certificates for Drugs and Cosmetics across country. The system will be shifted from…
